Fatal Outcome of COVID-19 Reactivation in a Patient With Multiple Myeloma After Reintroduction of Myeloma Therapy
Clinical Infection and Immunity · 2020
DOI: 10.14740/cii115 ↗At a glance
Journal article in Clinical Infection and Immunity, 2020. Written by Clara Cuellar Perez-Avila and 11 co-authors.
Abstract (original language)
Intet abstract tilgængeligt.
Cite
APA
Perez-Avila, C. C., Zamanillo, I., Iniguez, R., Gutierrez, X., Poza, M., Garcia-Sanchez, C., Zafra, D., Villegas, C., Sanchez-Pina, J. M., Alonso, R., Cedena, M. T., & Martinez-Lopez, J. (2020). Fatal Outcome of COVID-19 Reactivation in a Patient With Multiple Myeloma After Reintroduction of Myeloma Therapy. Clinical Infection and Immunity. https://doi.org/10.14740/cii115
Vancouver
Perez-Avila CC, Zamanillo I, Iniguez R, Gutierrez X, Poza M, Garcia-Sanchez C, et al. Fatal Outcome of COVID-19 Reactivation in a Patient With Multiple Myeloma After Reintroduction of Myeloma Therapy. Clinical Infection and Immunity. 2020. doi:10.14740/cii115
BibTeX
@article{PerezAvila2020,
author = {Perez-Avila, Clara Cuellar and Zamanillo, Irene and Iniguez, Rodrigo and Gutierrez, Xabier and Poza, Maria and Garcia-Sanchez, Cristina and Zafra, Denis and Villegas, Carolina and Sanchez-Pina, Jose Maria and Alonso, Rafael and Cedena, Maria Teresa and Martinez-Lopez, Joaquin},
title = {Fatal Outcome of COVID-19 Reactivation in a Patient With Multiple Myeloma After Reintroduction of Myeloma Therapy},
journal = {Clinical Infection and Immunity},
year = {2020},
doi = {10.14740/cii115}
}
EUVIMED